What is Insulinoma

An insulinoma is a rare, usually benign tumor of the pancreas that causes the body to produce excessive amounts of insulin. This overproduction leads to dangerously low blood sugar levels (hypoglycemia), which can cause symptoms ranging from confusion and dizziness to seizures if left untreated.

What is the underlying cause of an insulinoma?

An insulinoma originates in the beta cells of the pancreas, which are responsible for regulating blood sugar. Unlike a healthy pancreas, which releases insulin only when needed, an insulinoma functions autonomously, constantly secreting insulin regardless of the body’s actual glucose requirements. This creates a state of hyperinsulinemic hypoglycemia, where the brain and muscles are deprived of necessary fuel.

How common is an insulinoma and who does it affect?

Insulinoma is an exceptionally rare condition, with an estimated annual incidence of approximately 1 to 4 cases per million people. While it can occur at any age, it is most frequently diagnosed in adults between the ages of 30 and 60. There is no significant gender predilection, though some studies suggest a slightly higher prevalence in women. While most are sporadic, approximately 5-10% of cases are associated with Multiple Endocrine Neoplasia type 1 (MEN1), a hereditary genetic syndrome.

What are the primary characteristics of an insulinoma?

Differentiating an insulinoma from other causes of hypoglycemia is critical for effective management. Key clinical features include:

• Whipple’s Triad: The presence of hypoglycemic symptoms, low blood glucose levels, and the immediate relief of symptoms after sugar intake.


• Neuroglycopenic symptoms: Confusion, behavioral changes, visual disturbances, and loss of consciousness due to low glucose affecting the brain.


• Autonomic symptoms: Palpitations, sweating, and tremors as the body reacts to the sudden drop in blood sugar.

How is an insulinoma different from other pancreatic tumors?

Unlike most pancreatic cancers, approximately 90% of all insulinoma cases are benign and solitary. Because they are functional tumors, they often present with symptoms long before they grow large enough to be detected by standard imaging. At DiseaseMaps.org, 15 members have shared their experiences, highlighting the importance of early clinical suspicion in managing this rare condition.

Next steps

• Consult an endocrinologist to undergo a supervised 72-hour fast, the gold standard for diagnosing an insulinoma.


• Request advanced imaging, such as endoscopic ultrasound (EUS) or selective arterial calcium stimulation, to localize the tumor.


• Join our DiseaseMaps.org community to connect with others who have navigated the diagnostic process for this rare condition.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; always consult a qualified healthcare professional for diagnosis and treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Insulinoma


• Orphanet: Insulinoma (ORPHA:464)


• OMIM (Online Mendelian Inheritance in Man): Multiple Endocrine Neoplasia, Type I


• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)